STSA

Satsuma Pharmaceuticals (STSA)

Satsuma Pharmaceuticals Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:STSA

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2023/06/21	02:03	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(g) (15-12g)	NASDAQ:STSA	Satsuma Pharmaceuticals Inc
2023/06/15	21:00	GlobeNewswire Inc.	Satsuma Pharmaceuticals and SNBL Announce Three Abstracts on STS101 for the Acute Treatment of Migraine to be Presented at the American Headache Society’s 65th Annual Scientific Meeting	NASDAQ:STSA	Satsuma Pharmaceuticals Inc
2023/06/13	06:01	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:STSA	Satsuma Pharmaceuticals Inc
2023/06/09	19:04	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:STSA	Satsuma Pharmaceuticals Inc
2023/06/09	19:04	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:STSA	Satsuma Pharmaceuticals Inc
2023/06/09	05:46	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:STSA	Satsuma Pharmaceuticals Inc
2023/06/09	05:44	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:STSA	Satsuma Pharmaceuticals Inc
2023/06/09	05:44	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:STSA	Satsuma Pharmaceuticals Inc
2023/06/09	05:38	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:STSA	Satsuma Pharmaceuticals Inc
2023/06/09	05:33	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:STSA	Satsuma Pharmaceuticals Inc
2023/06/09	05:32	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:STSA	Satsuma Pharmaceuticals Inc
2023/06/09	05:31	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:STSA	Satsuma Pharmaceuticals Inc
2023/06/09	05:25	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:STSA	Satsuma Pharmaceuticals Inc
2023/06/08	22:23	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:STSA	Satsuma Pharmaceuticals Inc
2023/06/08	22:22	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:STSA	Satsuma Pharmaceuticals Inc
2023/06/08	22:20	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:STSA	Satsuma Pharmaceuticals Inc
2023/06/08	22:19	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:STSA	Satsuma Pharmaceuticals Inc
2023/06/08	22:18	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:STSA	Satsuma Pharmaceuticals Inc
2023/06/08	22:18	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:STSA	Satsuma Pharmaceuticals Inc
2023/06/08	22:17	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:STSA	Satsuma Pharmaceuticals Inc
2023/06/08	22:17	Edgar (US Regulatory)	Amended Statement of Ownership: Private Transaction (sc 13e3/a)	NASDAQ:STSA	Satsuma Pharmaceuticals Inc
2023/06/08	22:17	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:STSA	Satsuma Pharmaceuticals Inc
2023/06/08	22:15	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:STSA	Satsuma Pharmaceuticals Inc
2023/06/08	22:14	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:STSA	Satsuma Pharmaceuticals Inc
2023/06/08	22:13	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:STSA	Satsuma Pharmaceuticals Inc
2023/06/08	22:12	Edgar (US Regulatory)	Amended Statement of Ownership: Private Transaction (sc 13e3/a)	NASDAQ:STSA	Satsuma Pharmaceuticals Inc
2023/05/31	19:04	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:STSA	Satsuma Pharmaceuticals Inc
2023/05/31	19:03	Edgar (US Regulatory)	Amended Statement of Ownership: Private Transaction (sc 13e3/a)	NASDAQ:STSA	Satsuma Pharmaceuticals Inc
2023/05/26	19:40	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:STSA	Satsuma Pharmaceuticals Inc
2023/05/25	19:04	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:STSA	Satsuma Pharmaceuticals Inc